DK498476A - 2,-dimethyl-3-methoxycarbonyl-4-(2i-nitrophenyl)-1,4-dihydropyridin-5-carboxylsyreisobutylester flere fremgangsmader til fremstilling deraf samt dens anvendelse som coronarterapeutikum - Google Patents

2,-dimethyl-3-methoxycarbonyl-4-(2i-nitrophenyl)-1,4-dihydropyridin-5-carboxylsyreisobutylester flere fremgangsmader til fremstilling deraf samt dens anvendelse som coronarterapeutikum

Info

Publication number
DK498476A
DK498476A DK498476A DK498476A DK498476A DK 498476 A DK498476 A DK 498476A DK 498476 A DK498476 A DK 498476A DK 498476 A DK498476 A DK 498476A DK 498476 A DK498476 A DK 498476A
Authority
DK
Denmark
Prior art keywords
therapon
risobutylesters
dihydropyridine
methoxycarbonyl
nitrophenyl
Prior art date
Application number
DK498476A
Other languages
English (en)
Other versions
DK146762C (da
DK146762B (da
Inventor
E Wehinger
F Bossert
A Heise
S Kazda
K Stoepel
W Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK498476A publication Critical patent/DK498476A/da
Publication of DK146762B publication Critical patent/DK146762B/da
Application granted granted Critical
Publication of DK146762C publication Critical patent/DK146762C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK498476A 1975-11-05 1976-11-04 Analogifremgangsmaade til fremstilling af 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridin-5-carboxylsyreisobutylester DK146762C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2549568 1975-11-05
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
DK498476A true DK498476A (da) 1977-05-06
DK146762B DK146762B (da) 1983-12-27
DK146762C DK146762C (da) 1984-06-12

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
DK498476A DK146762C (da) 1975-11-05 1976-11-04 Analogifremgangsmaade til fremstilling af 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridin-5-carboxylsyreisobutylester

Country Status (27)

Country Link
JP (1) JPS5259161A (da)
AT (1) AT352129B (da)
AU (1) AU498964B2 (da)
BE (1) BE847968A (da)
BG (6) BG24803A3 (da)
CA (1) CA1085406A (da)
CH (2) CH623038A5 (da)
CS (1) CS200499B2 (da)
DE (1) DE2549568C3 (da)
DK (1) DK146762C (da)
ES (2) ES452986A1 (da)
FI (1) FI60704C (da)
FR (1) FR2330395A1 (da)
GB (1) GB1516793A (da)
GR (1) GR61241B (da)
HK (1) HK12681A (da)
IE (1) IE43984B1 (da)
IL (1) IL50817A (da)
LU (2) LU76133A1 (da)
NL (2) NL175915C (da)
NO (1) NO145574C (da)
NZ (1) NZ182502A (da)
PL (2) PL105940B1 (da)
PT (1) PT65797B (da)
RO (1) RO70295A (da)
SE (1) SE423542B (da)
ZA (1) ZA766622B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社 扉
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
IL50817A (en) 1979-07-25
ZA766622B (en) 1977-10-26
BG24804A3 (bg) 1978-05-12
BG24668A3 (bg) 1978-04-12
IE43984L (en) 1977-05-05
JPS5647185B2 (da) 1981-11-07
SE7612308L (sv) 1977-05-06
ES463166A1 (es) 1978-07-16
AT352129B (de) 1979-09-10
FI60704B (fi) 1981-11-30
NL7612198A (nl) 1977-05-09
PL105940B1 (pl) 1979-11-30
CS200499B2 (en) 1980-09-15
NL930035I2 (nl) 1993-10-01
RO70295A (ro) 1981-08-17
AU1935876A (en) 1978-05-11
HK12681A (en) 1981-04-10
FR2330395A1 (fr) 1977-06-03
NL930035I1 (nl) 1993-08-02
AU498964B2 (en) 1979-03-29
PL106084B1 (pl) 1979-11-30
FR2330395B1 (da) 1978-12-22
GR61241B (en) 1978-10-12
PT65797A (de) 1976-12-01
LU88275I2 (da) 1994-02-03
CA1085406A (en) 1980-09-09
PT65797B (de) 1978-05-12
BG25079A3 (bg) 1978-07-12
NZ182502A (en) 1978-07-28
IL50817A0 (en) 1977-01-31
SE423542B (sv) 1982-05-10
CH622779A5 (en) 1981-04-30
CH623038A5 (en) 1981-05-15
ES452986A1 (es) 1977-12-16
LU76133A1 (da) 1977-06-02
FI763160A7 (da) 1977-05-06
BE847968A (fr) 1977-05-04
JPS5259161A (en) 1977-05-16
DE2549568C3 (de) 1981-10-29
DK146762C (da) 1984-06-12
NO763608L (da) 1977-05-06
BG24805A3 (bg) 1978-05-12
NO145574C (no) 1982-04-21
ATA814276A (de) 1979-02-15
DK146762B (da) 1983-12-27
NO145574B (no) 1982-01-11
IE43984B1 (en) 1981-07-15
DE2549568B2 (de) 1980-08-21
BG24803A3 (bg) 1978-05-12
FI60704C (fi) 1982-03-10
BG25078A3 (bg) 1978-07-12
DE2549568A1 (de) 1977-05-18
GB1516793A (en) 1978-07-05
NL175915C (nl) 1985-01-16

Similar Documents

Publication Publication Date Title
SE7802487L (sv) Forfarande for framstellning av en som samt genom forfarandet framstelld som
DK282076A (da) Fremgangsmade til fremstilling af 2,3-dihydro6,7-disubstitueret-5-acyl-benzofuran-2-carboxylsyrer
DK107077A (da) 4,5-dichlorimidazol-2-carboxylsyrederivater, fremgangsmade til deres fremstilling samt deres anvendelse som skadedyrsbekempelsesmidler
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
AR218851A1 (es) Procedimiento para la preparacion de monoesteres de 17 alpha o 16 alpha o 21-retinoato de 11 beta,17 alpha,21-trihidroxi-3,20-diceto-4-pregnanos y-1,4-pregnatrienos
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO70629A (ro) Procedeu pentru prepararea 1,1-dioxidului de acid 3,4-dihidro-2-metil-4-oxo-2h-1,2-benzotiazin-3-carboxilic
DK315876A (da) 1,3,8-triazaspiro(4,5)decan-4-onderivater samt fremgangsmade til fremstilling heraf
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
NO147600C (no) Fremgangsmaate til fremstilling av tereftalsyre.
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE432765B (sv) Forfarande for framstellning av 2,9-dioxatricyklo/4,3,1,0?723?72,?727/dekaner
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
NO150157C (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-okso-dibenz(b,e)-oksepin-2-eddiksyre
DK12179A (da) Substituerede 1,5-cyclodiencarboxyl-syrederivater samt fremgangsmaade til fremstilling heraf
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK12279A (da) Substituerede 1,4-cyclohexadiencarboxylsyrederivater samt fremgangsmaade til femstilling heraf
AR210905A1 (es) Procedimiento de preparacion de 2,4-diamino-5-bencil-pirimidinas
DK329976A (da) 11,12-umettede 9alfa-fluorsteroider samt fremgangsmade til fremstilling deraf
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan

Legal Events

Date Code Title Description
PUP Patent expired